Key Insights

Highlights

Success Rate

71% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 59/100

Termination Rate

15.4%

2 terminated out of 13 trials

Success Rate

71.4%

-15.1% vs benchmark

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed with results

Key Signals

2 with results71% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (11)
P 4 (1)

Trial Status

Completed5
Recruiting4
Terminated2
Unknown1
Not Yet Recruiting1

Trial Success Rate

71.4%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (13)

Research Network

Activity Timeline